Export 29 results:
Author Title [ Type(Desc)] Year
Filters: Author is Cruz, C.D.  [Clear All Filters]
Journal Article
Cruz, C. D., Ferreira, D., McMahon, S. B., & Cruz, F. (2007). The activation of the ERK pathway contributes to the spinal c-fos expression observed after noxious bladder stimulation. Somatosensory and Motor Research, 24(1-2), 15 - 20.
Antunes-Lopes, T., Coelho, A., Pinto, R., Barros, S. C., et al. (2017). Author Reply. Urology, 99, 55 - 56.
Cruz, C. D., Coelho, A., Antunes-Lopes, T., & Cruz, F. (2015). Biomarkers of spinal cord injury and ensuing bladder dysfunction. Advanced Drug Delivery Reviews, 82, 153 - 159.
Frias, B., Allen, S., Dawbarn, D., Charrua, A., et al. (2013). Brain-derived neurotrophic factor, acting at the spinal cord level, participates in bladder hyperactivity and referred pain during chronic bladder inflammation. Neuroscience, 234, 88 - 102.
Charrua, A., Pinto, R., Taylor, A., Canelas, A., et al. (2015). Can the adrenergic system be implicated in the pathophysiology of bladder pain syndrome/interstitial cystitis? A clinical and experimental study. Neurourology and Urodynamics, 34(5), 489 - 496.
Charrua, A., Cruz, C. D., Jansen, D., Rozenberg, B., et al. (2015). Co-administration of transient receptor potential vanilloid 4 (TRPV4) and TRPV1 antagonists potentiate the effect of each drug in a rat model of cystitis. BJU International, 115(3), 452 - 460.
Coelho, A., Dinis, P., Pinto, R., Gorgal, T., et al. (2010). Distribution of the High-Affinity Binding Site and Intracellular Target of Botulinum Toxin Type A in the Human Bladder. European Urology, 57(5), 884 - 890.
Cruz, C. D., & Cruz, F. (2007). The ERK 1 and 2 pathway in the nervous system: From basic aspects to possible clinical applications in pain and visceral dysfunction. Current Neuropharmacology, 5(4), 244 - 252.
Charrua, A., Cruz, C. D., Narayanan, S., Gharat, L., et al. (2009). GRC-6211, a New Oral Specific TRPV1 Antagonist, Decreases Bladder Overactivity and Noxious Bladder Input in Cystitis Animal Models. Journal of Urology, 181(1), 379 - 386.
Coelho, A., Oliveira, R., Cruz, F., & Cruz, C. D. (2016). Impairment of sensory afferents by intrathecal administration of botulinum toxin A improves neurogenic detrusor overactivity in chronic spinal cord injured rats. Experimental Neurology, 285, 159 - 166.
Ferreira, J. G., Cruz, C. D., Neves, D., & Pignatelli, D. (2007). Increased extracellular signal regulated kinases phosphorylation in the adrenal gland in response to chronic ACTH treatment. Journal of Endocrinology, 192(3), 647 - 658.
Cruz, C. D., Avelino, A., McMahon, S. B., & Cruz, F. (2005). Increased spinal cord phosphorylation of extracellular signal-regulated kinases mediates micturition overactivity in rats with chronic bladder inflammation. European Journal of Neuroscience, 21(3), 773 - 781.
Cruz, C. D., Neto, F. L., Castro-Lopes, J., McMahon, S. B., & Cruz, F. (2005). Inhibition of ERK phosphorylation decreases nociceptive behaviour in monoarthritic rats. Pain, 116(3), 411 - 419.
Cruz, C. D., Charrua, A., Vieira, E., Valente, J., et al. (2008). Intrathecal delivery of resiniferatoxin (RTX) reduces detrusor overactivity and spinal expression of TRPV1 in spinal cord injured animals. Experimental Neurology, 214(2), 301 - 308.
Morgado, C., Pereira-Terra, P., Cruz, C. D., & Tavares, I. (2011). Minocycline completely reverses mechanical hyperalgesia in diabetic rats through microglia-induced changes in the expression of the potassium chloride co-transporter 2 (KCC2) at the spinal cord. Diabetes, Obesity and Metabolism, 13(2), 150 - 159.
Ochodnický, P., Cruz, C. D., Yoshimura, N., & Michel, M. C. (2011). Nerve growth factor in bladder dysfunction: Contributing factor, biomarker, and therapeutic target. Neurourology and Urodynamics, 30(7), 1227 - 1241.
Santos-Silva, A., Charrua, A., Cruz, C. D., Gharat, L., et al. (2012). Rat detrusor overactivity induced by chronic spinalization can be abolished by a transient receptor potential vanilloid 1 (TRPV1) antagonist. Autonomic Neuroscience: Basic and Clinical, 166(1-2), 35 - 38.
Coelho, A., Cruz, F., Cruz, C. D., & Avelino, A. (2012). Reply from Authors re: Prokar Dasgupta. Volume matters: Bladder injections of botulinum toxin type A. Eur Urol 2012;61:1185-6: Yes, Volume matters: Bladder injections of botulinum toxin type A. European Urology, 61(6), 1186 - 1187.
Frias, B., Santos, J., Morgado, M., Sousa, M. M., et al. (2015). The role of brain-derived neurotrophic factor (BDNF) in the development of neurogenic detrusor overactivity (NDO). Journal of Neuroscience, 35(5), 2146 - 2160.
Pinto, R., Frias, B., Allen, S., Dawbarn, D., et al. (2010). Sequestration of brain derived nerve factor by intravenous delivery of TrkB-Ig2 reduces bladder overactivity and noxious input in animals with chronic cystitis. Neuroscience, 166(3), 907 - 916.
Cruz, C. D., & Cruz, F. (2011). Spinal cord injury and bladder dysfunction: New ideas about an old problem. TheScientificWorldJournal, 11, 214 - 234.
Cruz, C. D., McMahon, S. B., & Cruz, F. (2006). Spinal ERK activation contributes to the regulation of bladder function in spinal cord injured rats. Experimental Neurology, 200(1), 66 - 73.
Coelho, A., Cruz, F., Cruz, C. D., & Avelino, A. (2012). Spread of onabotulinumtoxinA after bladder injection. Experimental study using the distribution of cleaved SNAP-25 as the marker of the toxin action. European Urology, 61(6), 1178 - 1184.
Charrua, A., Cruz, C. D., Cruz, F., & Avelino, A. (2007). Transient Receptor Potential Vanilloid Subfamily 1 is Essential for the Generation of Noxious Bladder Input and Bladder Overactivity in Cystitis. Journal of Urology, 177(4), 1537 - 1541.
Coelho, A., Wolf-Johnston, A. S., Shinde, S., Cruz, C. D., et al. (2015). Urinary bladder inflammation induces changes in urothelial nerve growth factor and TRPV1 channels. British Journal of Pharmacology, 172(7), 1691 - 1699.


Home | Site Map | Contacts | Credits | Privacy & Cookies | Intranet | Social Networks |

rua alfredo allen, 208, 4200-135 porto - portugal | tel +351 220 408 800 | email: info@ibmc.up.pt | © copyright 2010 ibmc